
    
      To investigate efficacy and safety of endostar combined with CHOP regimen as first line
      treatment for peripheral T cell lymphoma.The second subject is to clarify the association
      between expression of VEGF and prognosis in peripheral T cell lymphoma,unspecified(PTCL-U)
      and angioimmunoblastic T-cellLymphoma(AILT).Methods 15 cases of PTCL were enrolled in this
      study.Immunohistochemical staining was performed by EnVision method using antibodies VEGF.
    
  